These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25451835)

  • 1. Is hyperuricemia a risk factor for arteriosclerosis? Uric acid and arteriosclerosis in apolipoprotein e-deficient mice.
    Wakuda H; Uchida S; Ikeda M; Tabuchi M; Akahoshi Y; Shinozuka K; Yamada S
    Biol Pharm Bull; 2014; 37(12):1866-71. PubMed ID: 25451835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study.
    Chou HW; Chiu HT; Tsai CW; Ting IW; Yeh HC; Huang HC; Kuo CC;
    Nephrol Dial Transplant; 2018 Sep; 33(9):1620-1627. PubMed ID: 29165620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Open-Label, Cross-Over Comparison of the Effects of Benzbromarone and Febuxostat on Endothelial Function in Patients with Hyperuricemia.
    Nakata T; Ikeda S; Koga S; Yonekura T; Tsuneto A; Doi Y; Fukae S; Minami T; Kawano H; Maemura K
    Int Heart J; 2020 Sep; 61(5):984-992. PubMed ID: 32921665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of benzbromarone and allopurinol on the risk of chronic kidney disease in people with asymptomatic hyperuricemia.
    Lai SW; Liao KF; Kuo YH; Hwang BF; Liu CS
    Eur J Intern Med; 2023 Jul; 113():91-97. PubMed ID: 37127506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of uric acid-lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients.
    Wu J; Zhang YP; Qu Y; Jie LG; Deng JX; Yu QH
    Int J Rheum Dis; 2019 Aug; 22(8):1445-1451. PubMed ID: 31317680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of allopurinol and benzbromarone on the concentration of uridine in plasma.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
    Metabolism; 1997 Dec; 46(12):1473-6. PubMed ID: 9439546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
    Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E
    Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of low-dose benzbromarone to low-dose febuxostat in gout patients with renal uric acid underexcretion: comment on the article by Yan et al.
    Kawada T
    Arthritis Rheumatol; 2023 Sep; 75(9):1680-1681. PubMed ID: 36908047
    [No Abstract]   [Full Text] [Related]  

  • 10. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
    Reinders MK; van Roon EN; Houtman PM; Brouwers JR; Jansen TL
    Clin Rheumatol; 2007 Sep; 26(9):1459-65. PubMed ID: 17308859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum allantoin and urate in healthy subjects and effects of benzbromarone in gout patients.
    Kurajoh M; Koyama H; Shoji T; Sumida C; Yamamoto A; Tsutsumi Z; Moriwaki Y; Yamamoto T; Koga M
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):265-71. PubMed ID: 22456297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical images: Divergent patterns of joint remodeling following effective urate-lowering therapy in tophaceous gout.
    Dalbeth N; Doyle A; McQueen FM
    Arthritis Rheum; 2011 Jan; 63(1):266. PubMed ID: 20722028
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
    Chen CC; Hsu YJ; Lee TM
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1107-17. PubMed ID: 21622823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia.
    Ohta Y; Ishizuka A; Arima H; Hayashi S; Iwashima Y; Kishida M; Yoshihara F; Nakamura S; Kawano Y
    Hypertens Res; 2017 Mar; 40(3):259-263. PubMed ID: 27760998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update.
    Cicero AFG; Fogacci F; Kuwabara M; Borghi C
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
    Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
    Arntz HR; Dreykluft HR; Leonhardt H
    Fortschr Med; 1979 Jul; 97(27):1212-4. PubMed ID: 457017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.